Sentinus LLC’s Medtronic MDT Stock Holding History

Sentinus LLC’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$566K	Buy	7,233 +2,690	+59%	+$217K	0.05%	296
2026 Q1	$394K	Sell	4,543 -1,347	-23%	-$129K	0.04%	360
2025 Q4	$566K	Buy	+5,890	New	+$572K	0.05%	272

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Sentinus LLC's MDT Position: Q2 2026 in Review

Sentinus LLC increased its Medtronic (MDT) stake by 59% in Q2 2026, buying an estimated $217K and bringing the position to 7,233 shares worth $566K. The position accounts for 0.05% of the portfolio, ranked #296.

Sentinus LLC first reported a position in MDT in Q4 2025 and has held it in 3 quarters since. 1,602 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

Sentinus LLC held 7,233 shares of Medtronic worth $566K as of Q2 2026.
Sentinus LLC bought 2,690 Medtronic shares in Q2 2026, an estimated $217K.
Medtronic made up 0.05% of Sentinus LLC's portfolio in Q2 2026, its #296 holding.
Sentinus LLC first reported a position in Medtronic in Q4 2025 and has held it in 3 quarters since.
1,602 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Sentinus LLC's 13F filing for Q2 2026, filed 11 Aug 2026.